Clinical Trials Directory

Trials / Completed

CompletedNCT00107744

Clinical Trial of Protein and Blood Pressure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
352 (actual)
Sponsor
Tulane University · Academic / Other
Sex
All
Age
22 Years
Healthy volunteers
Accepted

Summary

The purpose of this randomized, double-blind, controlled trial is to examine the effect of soybean protein supplementation on blood pressure in persons with prehypertension or stage-1 hypertension.

Detailed description

Background: Epidemiologic studies suggest that vegetable protein intake is inversely related to blood pressure. Objectives: To examine the effect of soybean protein supplementation on blood pressure in persons with prehypertension or stage-1 hypertension Design: Randomized, double-blind, controlled trial Study Participants: 350 participants, aged 35-64 years, with an initial untreated systolic blood pressure of 130-159 mmHg and/or diastolic blood pressure of 80-99 mmHg Intervention: Study participants will be randomly assigned to take 40-grams of isolated soybean protein supplements per day or complex carbohydrate control for 12 weeks. Outcomes: Blood pressure measurements will be obtained using random-zero sphygmomanometers at baseline and during the trial at weeks 6 and 12. Net changes in systolic and diastolic blood pressure before and after the intervention is the primary outcome.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSoy protein-milk protein-carbohydrate40 grams of soy protein per day for 8 weeks, 40 grams of milk protein per day for 8 weeks, and 40 grams of carbohydrate per day for 8 weeks
DIETARY_SUPPLEMENTMilk protein-carbohydrate-soy protein40 grams of milk protein per day for 8 weeks, 40 grams of carbohydrate per day for 8 weeks, 40 grams of soy protein per day for 8 weeks.
DIETARY_SUPPLEMENTCarbohydrate-soy protein-milk protein40 grams of carbohydrate per day for 8 weeks, 40 grams of soy protein per day for 8 weeks, 40 grams of milk protein per day for 8 weeks.

Timeline

Start date
2003-09-01
Primary completion
2008-04-01
Completion
2008-04-01
First posted
2005-04-08
Last updated
2023-04-12
Results posted
2018-07-05

Source: ClinicalTrials.gov record NCT00107744. Inclusion in this directory is not an endorsement.